These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004661-15 A Phase III Randomized Study of CLORETAZINEâ„¢ (VNP40101M) and Cytosine Arabinoside (AraC) in Patients with Acute Myeloid Leukemia in First Relapse not-yet-due
Not reported 2006-001853-89 A phase II study of Cloretazine for elderly patients with de novo poor risk acute myelogenous leukemia. 2009-11-27 due-trials